Drugs / CTNS-RD-04
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03897361 | Jul 2019 → Sep 2024 | cystinosis | University of California, San Diego | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTNS-RD-04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03897361 ↗ |
| Known as | CTNS-RD-04-LB | “Investigational Product: CTNS-RD-04 or CTNS-RD-04-LB, where the suffix "-LB" stands for LentiBOOST” NCT03897361 ↗ |